Management of follicular lymphoma at first relapse
Canadian Hematology Today · 2022
DOI: 10.58931/cht.2022.116 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Hematology Today, 2022. Verfasst von Roopesh Kansara. Die Arbeit nennt 47 Literaturangaben.
Abstract (Originalsprache)
Follicular lymphoma (FL) is the most common subtype of indolent B-cell non-Hodgkin’s lymphoma (NHL). Histologically, it is subcategorized as grade 1, 2, 3A or 3B. FL, grade 3B is considered an aggressive form of the disease and is managed similar to diffuse large B-cell lymphoma (DLBCL). The intent of this article is to discuss the management of FL at first relapse. However, the knowledge of upfront management strategy is crucial in planning treatment in the event of a relapse.
Zitieren
APA
Kansara, R. (2022). Management of follicular lymphoma at first relapse. Canadian Hematology Today. https://doi.org/10.58931/cht.2022.116
Vancouver
Kansara R. Management of follicular lymphoma at first relapse. Canadian Hematology Today. 2022. doi:10.58931/cht.2022.116
BibTeX
@article{Kansara2022,
author = {Kansara, Roopesh},
title = {Management of follicular lymphoma at first relapse},
journal = {Canadian Hematology Today},
year = {2022},
doi = {10.58931/cht.2022.116}
}
EUVIMED